BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29512001)

  • 21. Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification.
    Yamamoto M; Kobayashi T; Hashimoto M; Kuroda S; Kawaoka T; Aikata H; Chayama K; Ohdan H
    BMC Cancer; 2021 Jun; 21(1):668. PubMed ID: 34090354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.
    Wu SS; Shan QY; Xie WX; Chen B; Huang Y; Guo Y; Xie XY; Lu MD; Peng BG; Kuang M; Shen SL; Wang W
    Clin Transl Oncol; 2020 Mar; 22(3):401-410. PubMed ID: 31172445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival after partial hepatectomy for sub-stage patients with intermediate stage hepatocellular carcinoma.
    Wei WX; Yang ZS; Lu LH; Li J; Lei ZQ; Wang K; Xia Y; Yan ZL; Shen F
    Int J Surg; 2018 Aug; 56():256-263. PubMed ID: 29935368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of Kinki Criteria, a Modified Substaging System, in Patients with Intermediate Stage Hepatocellular Carcinoma.
    Arizumi T; Ueshima K; Iwanishi M; Minami T; Chishina H; Kono M; Takita M; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ida H; Sakurai T; Kitano M; Nishida N; Kudo M
    Dig Dis; 2016; 34(6):671-678. PubMed ID: 27750236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC.
    Zhang ZQ; Xiong L; Zhou JJ; Miao XY; Li QL; Wen Y; Zou H
    World J Surg Oncol; 2018 Oct; 16(1):208. PubMed ID: 30326907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary liver resection for patients with cirrhosis and hepatocellular carcinoma: the role of surgery in BCLC early (A) and intermediate stages (B).
    Bell R; Pandanaboyana S; Lodge JPA; Prasad KR; Jones R; Hidalgo E
    Langenbecks Arch Surg; 2017 Jun; 402(4):575-583. PubMed ID: 27456677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Hepatitis B Virus DNA Level and Follow-up Interval With Hepatocellular Carcinoma Recurrence.
    Wang W; Tian SL; Wang H; Shao CC; Wang YZ; Li YL
    JAMA Netw Open; 2020 Apr; 3(4):e203707. PubMed ID: 32338753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
    Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
    J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver resection for HCC outside the BCLC criteria.
    Bhandare MS; Patkar S; Shetty N; Polnaya A; Kulkarni S; Dusane RR; Shrikhande SV; Goel M
    Langenbecks Arch Surg; 2018 Feb; 403(1):37-44. PubMed ID: 29199380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis after resection of hepatitis B virus-related hepatocellular carcinoma originating from non-cirrhotic liver.
    Zhou YM; Zhang XF; Li B; Sui CJ; Yang JM
    Ann Surg Oncol; 2014 Jul; 21(7):2406-12. PubMed ID: 24577811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.
    Zhong JH; Ke Y; Gong WF; Xiang BD; Ma L; Ye XP; Peng T; Xie GS; Li LQ
    Ann Surg; 2014 Aug; 260(2):329-40. PubMed ID: 24096763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
    Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment and prognosis study of spontaneous rupture hemorrhage in hepatocellular carcinoma: Recommendations for adding the A1 stage to the BCLC staging system.
    Ni Q; Jia H; Zhang Y; Lu J; Chang H
    Cancer Med; 2024 May; 13(10):e6952. PubMed ID: 38752672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
    Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
    Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
    Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
    Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
    World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LCSGJ-T classification, 6th or 5th edition TNM staging did not independently predict the long-term prognosis of HBV-related hepatocellular carcinoma after radical hepatectomy.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    J Surg Res; 2010 Mar; 159(1):538-44. PubMed ID: 19111323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new plasma biomarker enhance the clinical prediction of postoperative acute kidney injury in patients with hepatocellular carcinoma.
    Zhou X; Wang L; Wang G; Cheng X; Hu S; Ke W; Li M; Zhang Y; Song Z; Zheng Q
    Clin Chim Acta; 2017 Dec; 475():128-136. PubMed ID: 29031454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.